Analysis of the Execution of Centralized Drug Procurement Policy Based on Policy Implementation System Model

Corresponding author: Chen Hao, chenhao@hust.edu.cn

DOI: 10.12201/bmr.202310.00002

•  

  Abstract: Objective The objective of this study is to systematically identify the challenges and issues in the implementation of the centralized drug procurement policies, promote their sustainable development and enhance their quality and efficiency. Methods This research employs a combination of the policy implementation system model and thematic analysis method to analyze in-depth interview results from various stakeholders. Results and Conclusion Our research found the centralized drug procurement policy in Province N exhibits several issues in six aspects: policy goals and standards, policy resources, communication among organizations, characteristics of executing agencies, policy system environment, and preferences of policy implementers. The following recommendations are proposed: First, enhance policy flexibility and adaptability, address policy gaps and loopholes. Second, improve the quality and compatibility of digital resources, supplement the shortage of human resources, and ensure the supply of material resources. Third, establish effective inter-province information sharing and inter-departmental communication mechanisms. Fourth, clarify the main roles of executing agencies, strengthen policy execution oversight and evaluation, and standardize behaviors and responsibilities of all parties. Fifth, consider the characteristics and demands of the pharmaceutical market, actively explore the establishment of new policy mechanisms to adapt to environmental changes. Sixth, balance the preferences of policy implementers, guide all parties to form reasonable expectations and goals, and promote the improvement of policy execution effectiveness.

  Key words: centralized drug procurement; policy implementation system model; thematic analysis

  Submit time: 20 October 2023

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• SUN Wenjun, ZHAO Ziyin, CHENG Zheyu, LI Huining, ZHU He. Impact of the national centralized drug procurement policy on drug prices and utilization: a systematic review. 2023. doi: 10.12201/bmr.202303.00033

  songjia, fanchengxin, wangwanchen, aixufeng, liuxinlu, licuiyu, zhangyujie, liqiusha, wanganqi, fengzhiqiang, yinwenqiang, madongping. Study on Chinas centralized quantity purchasing policy for drugs from the perspective of stakeholders - a textual analysis based on policy tools. 2022. doi: 10.12201/bmr.202203.00006

  Li Hong-yu, Sun Qiang. Analysis of the impact of the Two Ballot System policy on drug supply in Shandong province. 2021. doi: 10.12201/bmr.202011.00015

  LIU MINGZHU, LU YUN. Research on the Implementation Effect of Expiration of National Pharmaceutical Centralized Volume-based Procurement Based on Intermittent Time Series: A Case Study of Hebei Province. 2023. doi: 10.12201/bmr.202306.00007

  WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. A study of price reduction sustainability in national volume-based drug procurement. 2023. doi: 10.12201/bmr.202305.00008

  Sun Yan, Zhu Zheng, Yang Li. Influencing factors analysis on price reduction in national volume-based drug procurement.. 2022. doi: 10.12201/bmr.202203.00008

  WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. Research on the price difference and regional distribution of selected drugs in Chinas centralized procurement. 2023. doi: 10.12201/bmr.202306.00008

  HAN Meng, WANG Shi-jia, HU Hao-yu, ZHAO Yan-jiao, CHEN Yong-fa. Comparative Study on Grouping Rules in Centralized Volume-based Procurement of Chinese Patent Medicine. 2023. doi: 10.12201/bmr.202312.00008

  LI Zhao, Zhao Ke, Zhou Lulin, Chen Sheng. Research on the Comparison and Development Countermeasures of Pharmaceutical Group Purchasing Modes from the Perspective of the Normalization of National Centralized Procurement. 2021. doi: 10.12201/bmr.202109.00037

  Li Xinyu, Shao Rong, Bai Mingyu, Li Dashuang, Yan Jianzhou. Text Quantitative Analysis of Pediatric Drug Security policy-- A two-dimensional framework based on policy tools and policy goals. 2022. doi: 10.12201/bmr.202209.00016

• ID	Submit time	Number	Download
  1	2023-06-29	bmr.202310.00002V1	Download

• Public  Anonymous  To author only Submit Comments